OS Therapies OverviewOS Therapies EBIT
EBIT (Earnings Before Interest and Taxes) analysis for OSTX.
Quarterly EBIT
-$10.17M
↑ 99.8% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$35.04M
↑ 99.3% YoY
Trailing 12 months ending Mar 31, 2026
OS Therapies OverviewEBIT (Earnings Before Interest and Taxes) analysis for OSTX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026